Beyond High Blood Pressure: Key Biomarkers Tested During a Cardiac Screening

A fasting blood glucose test gives a snapshot of blood sugar at the time the blood is drawn. Hemoglobin A1C looks at a longer period. It estimates average blood glucose during roughly the previous two to three months, which makes it useful for identifying patterns a single glucose reading might miss.

Results generally fall into ranges associated with normal blood sugar, prediabetes, or diabetes. A borderline result doesn't automatically mean heart disease is present. It can, however, change how the rest of a person's cardiovascular profile is interpreted.

Inflammation Markers Add Context to Other Risk Factors

Inflammation is involved in the development of atherosclerosis, the process behind plaque buildup in arteries. One blood test sometimes used to assess this part of cardiovascular risk is high-sensitivity C-reactive protein, or hs-CRP.

The liver produces C-reactive protein in response to inflammation. The high-sensitivity version of the test can detect relatively small amounts in the bloodstream. Higher hs-CRP levels have been associated with greater cardiovascular risk in certain patients, but the result needs careful interpretation.

An elevated number isn't specific to the heart. Infection, inflammatory diseases, an injury, and other conditions can also raise C-reactive protein. For this reason, hs-CRP doesn't work like a simple positive-or-negative test for heart disease.

Instead, it may provide another layer of information when considered with cholesterol, blood pressure, smoking history, diabetes status, age, family history, and other established risk factors. In some cases, a dependable heart doctor may use the result to clarify risk when a treatment decision isn't obvious from standard measurements alone.

Kidney Function Is Closely Connected to Cardiovascular Health

Kidney tests may seem separate from a heart screening, but the two organ systems have a close relationship. The kidneys filter waste from the blood and help regulate fluid, electrolytes, and blood pressure. Problems affecting the kidneys can also change cardiovascular risk. Two common measurements provide important information:

• Creatinine is a waste product filtered from the bloodstream by the kidneys. A higher blood creatinine level can be a sign of reduced kidney filtration, although interpretation depends on factors such as age and body composition.
• Estimated glomerular filtration rate, or eGFR, uses creatinine and other patient information to estimate how effectively the kidneys are filtering blood.

Doctors may also check urine for albumin. Albumin is a protein normally found in the blood, and increased amounts in urine can indicate kidney damage. Albumin in the urine has cardiovascular importance as well because it can be associated with higher risk even when kidney filtration hasn't declined dramatically.

Triglycerides Can Provide Additional Clues About Metabolic Health

Triglycerides are a type of fat carried in the bloodstream. High triglyceride levels may accompany metabolic problems tied to cardiovascular disease and can also be influenced by medications, certain medical conditions, and inherited lipid disorders.

Triglycerides are especially useful when viewed alongside HDL cholesterol and blood sugar. A pattern of high triglycerides, low HDL cholesterol, and abnormal glucose can point toward broader metabolic problems rather than an isolated cholesterol issue.

The number can change considerably based on recent food intake and other short-term factors, so the circumstances surrounding the test are important. A clinician may order a fasting lipid panel in some situations or repeat an unexpected result before making treatment decisions.

Certain Blood Tests Help Evaluate Heart Muscle Stress or Injury

Not every cardiac biomarker is used to estimate a person's long-term risk. Some tests answer whether the heart muscle is under unusual stress or has been injured. Two commonly discussed groups of biomarkers serve this purpose:

• Troponin is released into the bloodstream when heart muscle cells are injured. It plays an important role in evaluating suspected heart attacks, although other medical conditions can also raise troponin levels.
• BNP and NT-proBNP are biomarkers associated with pressure and volume changes inside the heart. Higher levels can support an evaluation for heart failure when considered with symptoms, examination findings, imaging, kidney function, and other information.

These aren't routine screening tests for every healthy person. Their value depends heavily on why the test was ordered. Someone arriving at an emergency department with chest pain may have serial troponin tests taken several hours apart because the pattern of change can be as important as the first number.

Biomarkers Are Most Useful When Viewed Alongside Your Full Clinical Picture

Lab results make more sense when they’re viewed with the rest of a patient’s health history. A cholesterol level that raises concern for one person may not carry the same level of risk for someone else. Age, smoking, diabetes, kidney disease, medications, family history, past cardiovascular problems, and imaging results can all change how a physician looks at the numbers.

Reference ranges aren’t the same thing as treatment goals, either. Someone who has already had a heart attack may be advised to keep LDL cholesterol much lower than a person with no known cardiovascular disease. The same is true for inflammatory markers. A higher result during an active infection may be expected, while that same result could deserve more attention in someone who otherwise feels well. Cardiac screening is most useful when these findings are considered together instead of relying on a single number to tell the whole story.

Are You Concerned About Your Heart Health?

At Capitol Cardiology Associates, a heart doctor can review findings in the context of your history, symptoms, medications, and other testing. If your screening results raise questions about cardiovascular risk, speaking with a cardiologist will clarify what the numbers mean and whether more extensive evaluation is appropriate.